Harmony Biosciences is a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative therapies for people living with rare and other neurological diseases with unmet medical needs. Guided by empathy, driven by science, and focused on innovation, we combine a strong commercial foundation with a growing pipeline of differentiated programs designed to advance treatment across multiple neurological conditions. By creating long-term value through scientific innovation, operational excellence, and disciplined execution, we invest in our people, our pipeline, and our mission to help improve patients’ lives. Follow us: Instagram → @harmony_biosciences X → @harmonybio #InHarmony #EmpathyAndInnovation View community guidelines: http://bit.ly/4v2Exc8
Looking for a particular Harmony Biosciences employee's phone or email?
The Harmony Biosciences annual revenue was $681.9 million in 2026.
Jeffrey Dayno is the President and Chief Executive Officer of Harmony Biosciences.
279 people are employed at Harmony Biosciences.
Harmony Biosciences is based in Plymouth Meeting, Pennsylvania.
The NAICS codes for Harmony Biosciences are [32541, 54, 32, 3254, 325, 541].
The SIC codes for Harmony Biosciences are [87, 873, 28, 283].